新型抗胆碱能支气管扩张剂Sch 1000与沙丁胺醇治疗慢性支气管炎的对比试验
Comparative trial of a new anticholinergic bronchodilator, Sch 1000, and salbutamol in chronic bronchitis.
作者信息
Poppius H, Salorinne Y
出版信息
Br Med J. 1973 Oct 20;4(5885):134-6. doi: 10.1136/bmj.4.5885.134.
Abstract
In 20 patients with chronic bronchitis and moderate or severe airways obstruction inhalation of 40 mug of a new anticholinergic drug, Sch 1000, was found to produce stronger and more persistent bronchodilation than inhalation of 200 mug of salbutamol.
摘要
在20例患有慢性支气管炎且有中度或重度气道阻塞的患者中，发现吸入40微克一种新型抗胆碱能药物Sch 1000所产生的支气管扩张作用比吸入200微克沙丁胺醇更强且更持久。
相似文献
1
Comparative trial of a new anticholinergic bronchodilator, Sch 1000, and salbutamol in chronic bronchitis.新型抗胆碱能支气管扩张剂Sch 1000与沙丁胺醇治疗慢性支气管炎的对比试验
Br Med J. 1973 Oct 20;4(5885):134-6. doi: 10.1136/bmj.4.5885.134.
2
Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma.异丙托溴铵气雾剂与沙丁胺醇在慢性支气管炎和哮喘中的比较
Br Med J. 1975 Feb 22;1(5955):430-2. doi: 10.1136/bmj.1.5955.430.
3
Inhalation of a new anticholinergic drug, SCH 1000, in asthma and chronic bronchitis: effect on airway resistance, thoracic gas volume, blood gases and exercise-induced asthma.新型抗胆碱能药物 SCH 1000 吸入治疗哮喘和慢性支气管炎：对气道阻力、肺总量、血气及运动诱发性哮喘的影响
Bull Physiopathol Respir (Nancy). 1972 May-Jun;8(3):643-53.
4
[The bronchodilator effect of aerosol beta-2-mimetic and anticholinergic agents in patients with chronic bronchitis].
Rev Mal Respir. 1990;7(1):59-63.
5
[Ventilatory and associated effects of a synthetic anticholinergic, SCH 1,000, in obstructive bronchopathies].
Bronchopneumologie. 1976 Sep-Oct;26(5):399-409.
6
[A comparative trial of bronchodilator effects of fenoteral and sch 1000 in chronic bronchitis (author's transl)].
Bull Eur Physiopathol Respir. 1976 Jul-Aug;12(4):433-43.
7
A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction.吸入用克仑特罗与沙丁胺醇治疗伴有可逆性气道阻塞的慢性支气管炎的比较
Eur J Respir Dis. 1980 Jun;61(3):143-50.
8
Salbutamol by pressure-packed aerosol and by intermittent positive pressure ventilation in chronic obstructive bronchitis.沙丁胺醇通过压力定量气雾剂及间歇性正压通气用于慢性阻塞性支气管炎的治疗。
Br J Dis Chest. 1978 Apr;72(2):122-4. doi: 10.1016/0007-0971(78)90021-9.
9
Bronchodilatory and circulatory effects of inhaling increasing doses of an anti-cholinergic drug, ipratropium bromide (SCH 1000).吸入递增剂量抗胆碱能药物异丙托溴铵（SCH 1000）的支气管扩张和循环效应
Scand J Respir Dis. 1975 Sep;56(3):138-49.
10
[Ventilatory and other effects of Sch 1000 aerosol in 54 patients with reversible bronchospasm].[Sch 1000气雾剂对54例可逆性支气管痉挛患者的通气及其他影响]
Rev Inst Hyg Mines (Hasselt). 1973;28(1):22-38.
引用本文的文献
1
Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing.哮喘药物及其在老年人中的潜在不良反应：处方建议
Drug Saf. 2001;24(14):1065-80. doi: 10.2165/00002018-200124140-00005.
2
Pharmacological treatment in acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期的药物治疗
Drugs Aging. 1998 Feb;12(2):129-37. doi: 10.2165/00002512-199812020-00005.
3
Comparison of the bronchodilator activities of oxitropium bromide, fenoterol, and their combination in patients with chronic obstructive pulmonary disease and bronchial asthma.
Clin Auton Res. 1993 Feb;3(1):41-4. doi: 10.1007/BF01819142.
4
Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者对低剂量和高剂量特布他林及异丙托溴铵的支气管扩张剂可逆性
Thorax. 1993 Nov;48(11):1151-5. doi: 10.1136/thx.48.11.1151.
5
Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.使用定量吸入器对慢性阻塞性肺疾病患者进行三种抗胆碱能药物与非诺特罗的比较剂量反应研究。
Thorax. 1995 Jan;50(1):62-6. doi: 10.1136/thx.50.1.62.
6
Atopy and bronchial reactivity in older patients with cystic fibrosis.老年囊性纤维化患者的特应性与支气管反应性
Thorax. 1980 Nov;35(11):807-13. doi: 10.1136/thx.35.11.807.
7
Synergism between ipratropium and theophylline in asthma.异丙托溴铵与茶碱在哮喘治疗中的协同作用。
Thorax. 1981 May;36(5):387-91. doi: 10.1136/thx.36.5.387.
8
Response to aerosol salbutamol, SCH 1000, and placebo in cystic fibrosis.囊性纤维化患者对雾化沙丁胺醇、SCH 1000和安慰剂的反应。
Thorax. 1980 Jul;35(7):531-5. doi: 10.1136/thx.35.7.531.
9
Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis.异丙托溴铵：其药理特性及在哮喘和慢性支气管炎中的治疗效果综述
Drugs. 1980 Oct;20(4):237-66. doi: 10.2165/00003495-198020040-00001.
10
A comparison between a combination of ipratropium bromide plus fenoterol in a single metered dose inhaler (Duovent) and salbutamol in asthma.在哮喘治疗中，对单剂量定量吸入器（Duovent，异丙托溴铵加非诺特罗组合制剂）与沙丁胺醇进行比较。
Postgrad Med J. 1983 Nov;59(697):724-5. doi: 10.1136/pgmj.59.697.724.
本文引用的文献
1
VARIATION OF DRUG ACTION ON AIRWAY OBSTRUCTION IN MAN.
Thorax. 1964 Sep;19(5):406-15. doi: 10.1136/thx.19.5.406.
2
A comparison of responses to bronchodilator drugs in chronic bronchitis and chronic asthma.慢性支气管炎和慢性哮喘对支气管扩张剂药物反应的比较。
Thorax. 1968 Jan;23(1):46-55. doi: 10.1136/thx.23.1.46.
3
[On the theory and praxis of total body plethysmography in the lung function analysis].[关于肺功能分析中全身体积描记法的理论与实践]
Prax Pneumol. 1967 Aug;21(8):449-71.
4
[Inhalation therapy with atropine derivatives].[阿托品衍生物的吸入疗法]
Med Klin. 1971 Feb 26;66(9):326-9.
5
Inhalation of a new anticholinergic drug, SCH 1000, in asthma and chronic bronchitis: effect on airway resistance, thoracic gas volume, blood gases and exercise-induced asthma.新型抗胆碱能药物 SCH 1000 吸入治疗哮喘和慢性支气管炎：对气道阻力、肺总量、血气及运动诱发性哮喘的影响
Bull Physiopathol Respir (Nancy). 1972 May-Jun;8(3):643-53.
Zotero 插件